What Dr. Dan Curran enjoys about leading Takeda’s rare genetics and hematology therapeutic unit 

Dr. Daniel Curran leads Takeda Pharmaceutical’s efforts to unlock innovation and deliver transformative medicines in a variety of rare-disease areas. Dan embraces learning from, collaborating with, and meeting members of the rare disease community while helping produce treatments that result in better health and a brighter future for rare. Watch Better Health, Brighter Future for Rare • Better Health, Brighte...